Cost-Effectiveness of Saxagliptin in Type 2 Diabetes in the United States

被引：0
|
作者：
Bergenheim, Klas
Williams, Setareh A.
Bergeson, Joette G.
Stern, Lee
Sriprasert, Michelle
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2369-PO
引用
收藏
页码：A629 / A630
页数：2
相关论文
共 50 条
  • [1] US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus
    Bergenheim, Klas
    Williams, Setareh A.
    Bergeson, Joette Gdovin
    Stern, Lee
    Sriprasert, Michelle
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2012, 4 (01) : 20 - 28
  • [2] Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden
    Granstrom, Ola
    Bergenheim, Klas
    McEwan, Phil
    Sennfalt, Karin
    Henriksson, Martin
    PRIMARY CARE DIABETES, 2012, 6 (02) : 127 - 136
  • [3] COST-EFFECTIVENESS OF SAXAGLIPTIN (ONGLYZA®) IN TYPE 2 DIABETES IN SOUTH AFRICA
    Juarez-Garcia, A.
    Casalvolone, D.
    Qatami, L.
    Bergenheim, K.
    Donato, B. M. K.
    VALUE IN HEALTH, 2012, 15 (04) : A180 - A180
  • [4] COST-EFFECTIVENESS ANALYSIS OF SAXAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN RUSSIA
    Arinina, E. E.
    Rashyd, M.
    VALUE IN HEALTH, 2012, 15 (04) : A172 - A172
  • [5] COST-EFFECTIVENESS ANALYSIS OF SAXAGLIPTIN IN THE TREATMENT OF DIABETES MELLITUS TYPE 2 IN SPAIN
    Ramirez de Arellano, A.
    Brosa, M.
    Franch, J.
    Mauricio, D.
    Alvarez, C.
    Sanchez-Zamorano, M.
    De Rivas, B.
    VALUE IN HEALTH, 2010, 13 (07) : A292 - A292
  • [6] COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS ACARBOSE AS SECOND-LINE THERAPY IN TYPE 2 DIABETES IN CHINA
    Gu, S.
    Shao, H.
    Zeng, Y.
    Shi, L.
    Dong, H.
    VALUE IN HEALTH, 2016, 19 (07) : A898 - A898
  • [7] Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
    Gu, Shuyan
    Zeng, Yuhang
    Yu, Demin
    Hu, Xiaoqian
    Dong, Hengjin
    PLOS ONE, 2016, 11 (11):
  • [8] Cost-effectiveness of second-line empagliflozin versus liraglutide for type 2 diabetes in the United States
    Reifsnider, Odette S.
    Pimple, Pratik
    Brand, Sarah
    Washington, Evelien Bergrath
    Shetty, Sharash
    Desai, Nihar R.
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 652 - 661
  • [9] THE COST-EFFECTIVENESS OF SAXAGLIPTIN WHEN ADED TO METFORMIN AND SULPHONYLUREA IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN SPAIN
    Sanchez-Covisa, J.
    Franch, J.
    Mauricio, D.
    Lopez-Martinez, N.
    Chuang, L. H.
    Capel, M.
    VALUE IN HEALTH, 2014, 17 (07) : A350 - A350
  • [10] Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United States
    Zhang, Xiaotong
    Marx, Carrie McAdam
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (03): : 276 - 284
12345